Cannabis Stocks

FDA Authorizes Marketing of the IQOS Tobacco Heating System as a Modified Risk Tobacco Product

Altria Group, Inc. (Altria) (NYSE: MO) announces today that the U.S. Food and Drug Administration (FDA) authorized the marketing of the IQOS tobacco heating system as a modified risk tobacco product with a reduced exposure claim. IQOS is the first next-generation inhalable tobacco product to be authorized as a modified risk tobacco product. Unlike cigarettes, the IQOS system heats but does not burn tobacco. Philip Morris USA (PM USA), under an exclusive licensing agreement with Philip Morris International (PMI), commercializes IQOS in the United States.

• 
  What Type Of Returns Would Philip Morris International's(NYSE:PM) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

  Simply Wall St.
• 
  FDA Authorizes Marketing of IQOS Tobacco Heating System with 'Reduced Exposure' Information

  PR Newswire

Top Ranked Value Stocks to Buy for July 7th

Top Ranked Value Stocks to Buy for July 7th

• 
  New Strong Buy Stocks for July 6th

  Zacks
• 
  Top Ranked Income Stocks to Buy for July 6th

  Zacks

The Zacks Analyst Blog Highlights: Scotts Miracle-Gro, HEXO and Aurora Cannabis

The Zacks Analyst Blog Highlights: Scotts Miracle-Gro, HEXO and Aurora Cannabis

• 
  Get Ready for a Green Rush in the Second Half: 3 Must Buys

  Zacks
• 
  Scotts Miracle-Gro Up 33% in 3 Months: What's Driving It?

  Zacks

Why Aurora Cannabis Fell 12.9% in June

Despite selling assets and laying out a massive restructuring plan, shares fell back after a big May run.

Why Anheuser-Busch InBev Tumbled 39.7% in the First Half of 2020

Shares of Anheuser-Busch InBev (NYSE: BUD) fell 39.7% over the first six months of 2020, according to data from S&P Global Market Intelligence, versus a 3% loss for the S&P 500 index. Part of Anheuser-Busch's problem is that beer consumption remains on the decline in the U.S. Consumer preferences overseas aren't shifting so dramatically, but the domestic market is the company's largest. While the brewer is participating in the hard seltzer trend — one of the fastest-growing segments in alcohol — it trails far behind the category's leaders, like Mark Anthony Brands' White Claw and Boston Beer's Truly.

• 
  Why Energy Giants Chevron, ExxonMobil, and Enterprise All Lost at Least 25% in the First Half of 2020

  Motley Fool
• 
  Why Marathon Oil Stock Plunged Nearly 55% in the First Half of 2020

  Motley Fool

4 Value Stocks to Buy in a Recovering Economy

Vitals of financial markets and the U.S. economy are recovering gradually, making way for value stocks to gain pace ahead.

2 Top Stocks for Retirees

First up is General Mills (NYSE: GIS). While some industries' revenues evaporated, General Mills accelerated its growth. For fiscal 2020, the General Mills pet food segment grew 18%, tripling the overall company's pace, and there is reason to believe that can continue.

• 
  Has Alamos Gold (AGI) Outpaced Other Basic Materials Stocks This Year?

  Zacks
• 
  Is 1800 FLOWERS.COM (FLWS) Stock Outpacing Its Retail-Wholesale Peers This Year?

  Zacks

The 5 Best Pot Stocks in the First Half of 2020

Until the end of the first quarter of 2019, you could have thrown a dart at a list of publicly traded pot stocks and likely come out a significant winner. With people stuck at home, lawn and garden projects are there to keep them busy.

• 
  Get Ready for a Green Rush in the Second Half: 3 Must Buys

  Zacks
• 
  The Zacks Analyst Blog Highlights: Scotts Miracle-Gro, HEXO and Aurora Cannabis

  Zacks

3 Best-Performing Dividend Aristocrats in the First Half of 2020: Are They Buys Now?

Exceptional dividend track records. Exceptional stock performances in the first six months of the year.

Scotts Miracle-Gro Up 33% in 3 Months: What's Driving It?

Upbeat views and bright prospects in the Hawthorne business are driving Scotts Miracle-Gro's (SMG) shares.

• 
  Get Ready for a Green Rush in the Second Half: 3 Must Buys

  Zacks
• 
  The Zacks Analyst Blog Highlights: Scotts Miracle-Gro, HEXO and Aurora Cannabis

  Zacks

4 Reasons to Own AbbVie Stock as Coronavirus Woes Linger

AbbVie's (ABBV) key drug, Humira is seeing strong demand in the United States while generics are eroding ex-U.S. sales. New drugs Skyrizi and Rinvoq are off to a strong start.

These 3 Value Stocks Are Absurdly Cheap Right Now

These companies have low P/E ratios and high dividend yields and investors stand to profit from that combination.

Are Options Traders Betting on a Big Move in Tilray (TLRY) Stock?

Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.

• 
  Implied Volatility Surging for Park Hotels & Resorts (PK) Stock Options

  Zacks
• 
  Are Options Traders Betting on a Big Move in Forescout Technologies (FSCT) Stock?

  Zacks

5 Popular Stocks I Wouldn't Buy With Free Money

Uncertainty and panic related to the coronavirus disease 2019 (COVID-19) pandemic completely pulled the rug out from beneath the stock market and ultimately sent the benchmark S&P 500 lower by 34% in a mere 33 days. The recently ended quarter featured the best returns for the broad-market indexes since 1998, with the technology-focused Nasdaq Composite galloping to new all-time highs. Right now, there are five exceptionally popular stocks that investors can't seem to get enough of lately that, frankly, I wouldn't buy with free money.

Get Ready for a Green Rush in the Second Half: 3 Must Buys

With more states in the US and Canada likely to legalize marijuana and calls for marijuana decriminalization growing louder, the cannabis industry is poised to bounce back in the second half.

• 
  The Zacks Analyst Blog Highlights: Scotts Miracle-Gro, HEXO and Aurora Cannabis

  Zacks
• 
  Scotts Miracle-Gro Up 33% in 3 Months: What's Driving It?

  Zacks

Canopy Growth Corporation (CGC): Are Hedge Funds Right About This Stock?

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […]

• 
  Were Hedge Funds Right About Western Digital Corporation (WDC)?

  Insider Monkey
• 
  Should You Avoid US Concrete Inc (USCR)?

  Insider Monkey

5 Companies Owned by MO

UST, John Middleton, Burger Söhne Holding AG, Juul, and Cronos Group are major companies owned by Altria.

• 
  What Type Of Returns Would Philip Morris International's(NYSE:PM) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

  Simply Wall St.
• 
  FDA Authorizes Marketing of IQOS as a Modified Risk Tobacco Product

  Business Wire

AbbVie to Host Second-Quarter 2020 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its second-quarter 2020 financial results on Friday, July 31, 2020, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie's Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

• 
  RLI Second Quarter Earnings Release & Teleconference

  Business Wire
• 
  Howard Bancorp, Inc. Announces Second Quarter 2020 Conference Call Details

  Business Wire

Shareholders Of AbbVie (NYSE:ABBV) Must Be Happy With Their 75% Return

If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share...

• 
  Ag Growth International (TSE:AFN) Share Prices Have Dropped 53% In The Last Three Years

  Simply Wall St.
• 
  Air Canada's(TSE:AC) Share Price Is Down 59% Over The Past Year.

  Simply Wall St.

Were Hedge Funds Right About Quitting Altria Group Inc (MO)?

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […]

• 
  Were Hedge Funds Right About Selling American International Group Inc (AIG)?

  Insider Monkey
• 
  Hedge Funds Are Crazy About Strongbridge Biopharma plc (SBBP)

  Insider Monkey

Loss-Making Tilray, Inc. (NASDAQ:TLRY) Expected To Breakeven

Tilray, Inc.'s (NASDAQ:TLRY): Tilray, Inc. engages in the research, cultivation, processing, and distribution of...

• 
  Spectral Medical Inc. (TSE:EDT) Is Expected To Breakeven

  Simply Wall St.
• 
  Flexion Therapeutics, Inc. (NASDAQ:FLXN): When Will It Breakeven?

  Simply Wall St.